Thromb Haemost 1974; 31(02): 339-345
DOI: 10.1055/s-0038-1649168
Original Article
Schattauer GmbH

Antithrombin III Deficiency in Maturity Onset Diabetes Mellitus and Atherosclerosis

Authors

  • R. N Banerjee

    1   Department of Haematology and Nuclear Medicine, Safdarjang Hospital, New Delhi-16
  • A. L Sahni

    1   Department of Haematology and Nuclear Medicine, Safdarjang Hospital, New Delhi-16
  • V Kumar

    1   Department of Haematology and Nuclear Medicine, Safdarjang Hospital, New Delhi-16
  • M Arya

    1   Department of Haematology and Nuclear Medicine, Safdarjang Hospital, New Delhi-16
Weitere Informationen

Publikationsverlauf

Received 26. September 1973

Accepted 26. November 1973

Publikationsdatum:
29. Juni 2018 (online)

Preview

Summary

Antithrombin III activity and thrombin times were assayed in maturity onset diabetics, atherosclerotic patients and normal subjects. There was a close correlation between the Antithrombin III activity and thrombin times in all three groups. Reductions in these measurements in diabetes mellitus and atherosclerosis, independent of thromboembolic phenomena, support the theory of Antithrombin III deficiency in these diseases.